A case study on the Ayurvedic management of cerebral palsy

Sagar Mahendrabhai Bhinde1

  • 1Department of Kaumarbhritya, G. J. Patel Institute of Ayurvedic Studies and Research Centre, New V V Nagar, Anand, Gujarat, India.

Insights

Ayurveda treatment modalities, including Panchakarma and internal medicines, showed a 10-15% improvement in a 3-year-old child with spastic cerebral palsy (CP) over 94 days.

Area of Science:

  • Ayurvedic Medicine
  • Neurology
  • Pediatric Neurology

Background:

  • Cerebral palsy (CP) is a primary cause of childhood disability, characterized by nonprogressive neuromotor dysfunction of cerebral origin.
  • Ayurveda classifies related conditions into sahaja (hereditary), garbhaja (congenital), and jātaja (psychosomatic) categories, acknowledging its multifactorial nature and varied clinical presentations.
  • Currently, no definitive cure exists for the diverse types and subtypes of cerebral palsy.

Observation:

  • A 3-year-old male child diagnosed with spastic cerebral palsy was treated using a combination of Ayurvedic therapeutic approaches.
  • The treatment regimen spanned 94 days and incorporated Panchakarma procedures alongside internal Ayurvedic medications.

Findings:

  • The integrated Ayurvedic treatment approach resulted in a notable improvement in the child's overall condition.
  • Quantifiable results indicated a 10-15% enhancement in the overall therapeutic effect following the 94-day intervention.

Implications:

  • This case study suggests the potential efficacy of Ayurvedic interventions in managing spastic cerebral palsy in pediatric patients.
  • Further research into Ayurvedic treatment modalities for cerebral palsy could offer novel therapeutic avenues for improving childhood functional outcomes.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.7K